Tomohito Kuwako

A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations

Hisao Imai, Kyoichi Kaira, Kensuke Suzuki et al. · Lung Cancer · 2018 · 51 citations

Oncology, Elderly Patients, Pathology +7

First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations

Tomohito Kuwako, Hisao Imai, Tomomi Masuda et al. · Cancer Chemotherapy and Pharmacology · 2015 · 22 citations

First-line Gefitinib Treatment, Elderly Patients, Medicine +8

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer

Hisao Imai, Tomohito Kuwako, Kyoichi Kaira et al. · Cancer Chemotherapy and Pharmacology · 2017 · 20 citations · Full text

Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study

Norimitsu Kasahara, Noriaki Sunaga, Tomohito Kuwako et al. · Supportive Care in Cancer · 2020 · 14 citations

Oncology, Medicine, Phase Ii Study +5

Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations

Tomomi Masuda, Hisao Imai, Tomohito Kuwako et al. · Clinical & Translational Oncology · 2015 · 14 citations

First-line Gefitinib Treatment, Medicine, Platinum Combination Chemotherapy +8